Viral Hepatitis
📧 Sign up to get email alerts when something new happens for Viral Hepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Prospective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)
A prospective observational multicenter study in Kazakhstan to assess how often chronic kidney disease is diagnosed in patients with acute h…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis [Phase 3]
A Phase 3 trial evaluating Lipiocis as adjuvant treatment for hepatocellular carcinoma has completed; sponsor information includes ANRS and …
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings [NA]
A completed clinical trial in Malaysia examined opioid use disorder and infections (HIV, tuberculosis, and hepatitis) among people in the cr…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function [Phase 1]
Phase 1 study evaluating the pharmacokinetics, safety, and tolerability of pevifoscorvir sodium (ALG-000184) in adults with moderate hepatic…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
The GREAT1.0 genomic resources study is currently suspended, with no trial results reported at this time.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Repeatability and Reproducibility of Multiparametric MRI
A clinical trial update reports on the repeatability and reproducibility of multiparametric MRI for evaluating liver diseases across several…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency
This clinical trial update indicates the study is currently recruiting to evaluate populations at risk of developing chronic hepatitis linke…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
This clinical trial update describes a program to distribute low dead-space injecting equipment to people who inject drugs in low- and middl…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids
A clinical trial is evaluating low-dose corticosteroids to manage hepatitis caused by immune checkpoint inhibitors in cancer patients, curre…
-
FDA approval · 2025-08-20FDA Approved: LAMIVUDINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application to authorize lamivudine oral (generic) from Chartwell RX, LLC.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®
An ongoing feasibility study evaluating simultaneous screening for hepatitis B, hepatitis C, and HIV among drug users and vulnerable populat…
-
FDA approval · 2025-05-08FDA Approved: LAMIVUDINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for lamivudine submitted by Camber Pharmaceuticals, expanding the approved product to lamivudine…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) [Phase 2]
A Phase 2 study evaluating BI 685509 alone or with empagliflozin for liver cirrhosis due to viral hepatitis or non-alcoholic steatohepatitis…
-
CLINICAL_TRIALS other · 2025-04-09Clinical Trial Update: VIRal Hepatitis and GAllstone Disease Study
Clinical trial NCT04222803 investigating viral hepatitis and gallstone disease at Göteborg University has been suspended.
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Conventional Ultrasound Versus Remote Ultraportable ulTrasound in the Context of Viral Hepatitis
The study compares conventional ultrasound to a remote ultraportable ultrasound in the setting of viral hepatitis. Recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) [NA]
A completed clinical trial evaluated the efficacy of albumin dialysis using the MARS system to treat hepatic encephalopathy in patients with…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial assessing the safety, tolerability, and preliminary efficacy of HepaCure in Chinese patients with acute-on-…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: LivQ-box® Parameters in the Diagnosis of Liver Inflammation
Clinical trial update describing the use of LivQ-box parameters to diagnose liver inflammation, with recruitment currently ongoing.
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Acute Hepatitis in Pediatrics
A pediatric clinical trial investigating acute hepatitis is currently recruiting in Bologna, Italy.
-
FDA approval · 2024-12-04FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approves a supplemental application for Emtricitabine and Tenofovir Disoproxil Fumarate by Zydus Pharmaceuticals USA Inc., confirming re…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
This completed clinical trial compared magnetic resonance elastography (MRE) and corrected-T1 (cT1) for diagnosing fibrosis and inflammation…
-
FDA approval · 2024-11-21FDA Approved: EMTRICITABINE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Emtricitabine submitted by Cipla USA Inc., updating the approved labeling for the drug.
-
CLINICAL_TRIALS withdrawal · 2024-11-19Clinical Trial Update: Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry
A registry trial evaluating endoscopic ultrasound-guided liver biopsy and portal pressure measurements has been withdrawn from ClinicalTrial…
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Risk Factors and Frequency of Acute Idiopathic Hepatitis in Children at Assiut Children Hospital
This clinical trial update (NCT06454760) explores risk factors and frequency of acute idiopathic hepatitis in children at Assiut Children's …
-
FDA approval · 2023-12-11FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
The FDA approved a supplemental application for Pegasys (peginterferon alfa-2a) submitted by pharmaand GmbH.